Sihuan Pharmaceutical Holdings Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Sihuan Pharmaceutical are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Sihuan Pharmaceutical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Sihuan Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 4.6 B | |
| Total Cashflows From Investing Activities | -337.6 M |
Sihuan |
Sihuan Pharmaceutical Relative Risk vs. Return Landscape
If you would invest (100.00) in Sihuan Pharmaceutical Holdings on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Sihuan Pharmaceutical Holdings or generate -100.0% return on investment over 90 days. Sihuan Pharmaceutical Holdings is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Sihuan, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Sihuan Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sihuan Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Sihuan Pharmaceutical Holdings, and traders can use it to determine the average amount a Sihuan Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SHPHF |
Based on monthly moving average Sihuan Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sihuan Pharmaceutical by adding Sihuan Pharmaceutical to a well-diversified portfolio.
Sihuan Pharmaceutical Fundamentals Growth
Sihuan Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Sihuan Pharmaceutical, and Sihuan Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sihuan Pink Sheet performance.
| Return On Equity | -0.0487 | |||
| Return On Asset | -4.0E-4 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0) % | |||
| Current Valuation | 506.36 M | |||
| Shares Outstanding | 9.33 B | |||
| Price To Earning | 8.75 X | |||
| Price To Book | 0.81 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 3.29 B | |||
| EBITDA | 914.73 M | |||
| Cash And Equivalents | 5.25 B | |||
| Cash Per Share | 0.56 X | |||
| Total Debt | 844.75 M | |||
| Debt To Equity | 0.14 % | |||
| Book Value Per Share | 0.78 X | |||
| Cash Flow From Operations | 665.29 M | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 14.5 B | |||
| Retained Earnings | 5.54 B | |||
| Current Asset | 6.17 B | |||
| Current Liabilities | 1.51 B | |||
Things to note about Sihuan Pharmaceutical performance evaluation
Checking the ongoing alerts about Sihuan Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Sihuan Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sihuan Pharmaceutical is not yet fully synchronised with the market data | |
| Sihuan Pharmaceutical has some characteristics of a very speculative penny stock | |
| Sihuan Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| About 55.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Sihuan Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sihuan Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Sihuan Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sihuan Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sihuan Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sihuan Pharmaceutical's pink sheet. These opinions can provide insight into Sihuan Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Sihuan Pink Sheet
If you are still planning to invest in Sihuan Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sihuan Pharmaceutical's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |